The Signal: Avalyn Pharma

Published

About this Series

The Signal

The Signal is Nasdaq’s editorial business news series, showcasing the leading companies that are moving markets. Episodes feature candid conversations with founders and CEOs across industries, unpacking the latest technologies, innovations, and applications that are driving change across the economy.

In this episode of The Signal, Lynn Baranowski, CEO of Avalyn Pharma, discusses the company's mission to improve outcomes for patients living with pulmonary fibrosis and other rare respiratory diseases. She shares how Avalyn is advancing inhaled therapies designed to deliver proven medicines directly to the lungs, highlights the company's clinical progress, and reflects on the importance of patient-centered innovation and strong female leadership in biotech.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now